Summary

The Global Pharmaceutical Impurity Synthesis and Isolation Services Market is valued at approximately USD 1.13 billion in 2023 and is poised to expand at a remarkable CAGR of 8.10% over the forecast period from 2024 to 2032. This burgeoning growth can be attributed to the increasing complexity of pharmaceutical formulations and the growing emphasis on ensuring the purity and safety of drugs. Impurity synthesis and isolation services have emerged as an indispensable component in drug development and regulatory compliance, helping pharmaceutical companies maintain stringent quality standards.
As the pharmaceutical industry undergoes unprecedented advancements, the need for precise identification, synthesis, and isolation of impurities has become paramount. These services enable manufacturers to replicate and analyze impurities in controlled settings, ensuring accurate assessments of their impact on drug efficacy and safety. This evolution is also a response to mounting regulatory scrutiny, as global authorities demand higher levels of transparency and reliability in impurity profiling. Moreover, the integration of advanced analytical techniques, such as high-resolution mass spectrometry and nuclear magnetic resonance, has significantly enhanced the precision of impurity isolation, driving the adoption of these services.
The global market is further bolstered by a confluence of factors, including the escalating prevalence of chronic diseases, a surge in drug development pipelines, and increased investments in pharmaceutical research. For instance, leading organizations are channeling substantial resources into impurity characterization to expedite the approval process for novel therapies. However, challenges such as the high costs associated with sophisticated analytical equipment and the lack of skilled professionals in emerging markets could hinder market growth during the forecast period.
Regional dynamics play a pivotal role in shaping the trajectory of this market. North America holds the lion's share, driven by its well-established pharmaceutical infrastructure, significant R&D investments, and robust regulatory frameworks. Europe closely follows, with a strong focus on maintaining pharmaceutical quality standards and fostering innovation. Meanwhile, the Asia Pacific region is projected to witness the fastest growth, fueled by increasing drug production, rising healthcare expenditure, and growing awareness of regulatory compliance in countries like India and China. Additionally, Latin America and the Middle East & Africa regions present untapped opportunities, supported by improving healthcare access and expanding pharmaceutical manufacturing capabilities.
Major market players included in this report are:
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Charles River Laboratories International, Inc.
• Agilent Technologies, Inc.
• Waters Corporation
• Eurofins Scientific
• Wuxi AppTec
• SGS SA
• Toxikon Corporation
• Alcami Corporation
• AMRI Global
• Cambrex Corporation
• Dalton Pharma Services
• LGC Limited
• BioReliance Corporation
The detailed segments and sub-segment of the market are explained below:
By Service:
• Synthesis Services
• Isolation Services
• Analytical Services
By Impurity Type:
• Process Impurities
• Degradation Impurities
• Residual Solvents
• Others
By Technique:
• Chromatography
• Spectroscopy
• Others
By Application:
• Drug Discovery
• Drug Manufacturing
• Quality Control
By End-Use:
• Pharmaceutical Companies
• Biotechnology Companies
• CROs (Contract Research Organizations)
By Region:
• North America
o U.S.
o Canada
• Europe
o UK
o Germany
o France
o Spain
o Italy
o Rest of Europe
• Asia Pacific
o China
o India
o Japan
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Rest of Latin America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
Key Takeaways:
• Market estimates and forecasts for 10 years from 2022 to 2032.
• Annualized revenues and regional-level analysis for each market segment.
• Comprehensive analysis of geographical landscapes with country-level insights across major regions.
• Competitive landscape featuring detailed profiles and strategies of major market players.
• Analysis of key business strategies and recommendations for future market approaches.
• Comprehensive analysis of the competitive structure of the market.
• Demand-side and supply-side analysis of the market.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1. Global Pharmaceutical Impurity Synthesis and Isolation Services Market Executive Summary 1.1. Global Pharmaceutical Impurity Synthesis and Isolation Services Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Service
1.3.2. By Impurity Type
1.3.3. By Technique
1.3.4. By Application
1.3.5. By End-use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Pharmaceutical Impurity Synthesis and Isolation Services Market Definition and Research Assumptions 2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Pharmaceutical Impurity Synthesis and Isolation Services Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Complexity of Pharmaceutical Formulations
3.1.2. Growing Emphasis on Drug Purity and Safety
3.1.3. Advancements in Analytical Techniques
3.2. Market Challenges
3.2.1. High Costs of Sophisticated Analytical Equipment
3.2.2. Lack of Skilled Professionals in Emerging Markets
3.3. Market Opportunities
3.3.1. Rising Investments in Pharmaceutical Research
3.3.2. Expansion of Drug Development Pipelines
3.3.3. Enhancement of Regulatory Compliance Requirements
Chapter 4. Global Pharmaceutical Impurity Synthesis and Isolation Services Market Industry Analysis 4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Pharmaceutical Impurity Synthesis and Isolation Services Market Size & Forecasts by Service 2022-2032 5.1. Segment Dashboard
5.2. Global Pharmaceutical Impurity Synthesis and Isolation Services Market: Service Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
5.2.1. Synthesis Services
5.2.2. Isolation Services
5.2.3. Analytical Services
Chapter 6. Global Pharmaceutical Impurity Synthesis and Isolation Services Market Size & Forecasts by Impurity Type 2022-2032 6.1. Segment Dashboard
6.2. Global Pharmaceutical Impurity Synthesis and Isolation Services Market: Impurity Type Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
6.2.1. Process Impurities
6.2.2. Degradation Impurities
6.2.3. Residual Solvents
6.2.4. Others
Chapter 7. Global Pharmaceutical Impurity Synthesis and Isolation Services Market Size & Forecasts by Technique 2022-2032 7.1. Segment Dashboard
7.2. Global Pharmaceutical Impurity Synthesis and Isolation Services Market: Technique Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
7.2.1. Chromatography
7.2.2. Spectroscopy
7.2.3. Others
Chapter 8. Global Pharmaceutical Impurity Synthesis and Isolation Services Market Size & Forecasts by Application 2022-2032 8.1. Segment Dashboard
8.2. Global Pharmaceutical Impurity Synthesis and Isolation Services Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
8.2.1. Drug Discovery
8.2.2. Drug Manufacturing
8.2.3. Quality Control
Chapter 9. Global Pharmaceutical Impurity Synthesis and Isolation Services Market Size & Forecasts by End-use 2022-2032 9.1. Segment Dashboard
9.2. Global Pharmaceutical Impurity Synthesis and Isolation Services Market: End-use Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
9.2.1. Pharmaceutical Companies
9.2.2. Biotechnology Companies
9.2.3. CROs (Contract Research Organizations)
Chapter 10. Global Pharmaceutical Impurity Synthesis and Isolation Services Market Size & Forecasts by Region 2022-2032 10.1. North America Pharmaceutical Impurity Synthesis and Isolation Services Market
10.1.1. U.S. Pharmaceutical Impurity Synthesis and Isolation Services Market
10.1.1.1. Synthesis Services Breakdown Size & Forecasts, 2022-2032
10.1.1.2. Isolation Services Breakdown Size & Forecasts, 2022-2032
10.1.1.3. Analytical Services Breakdown Size & Forecasts, 2022-2032
10.1.2. Canada Pharmaceutical Impurity Synthesis and Isolation Services Market
10.1.2.1. Synthesis Services Breakdown Size & Forecasts, 2022-2032
10.1.2.2. Isolation Services Breakdown Size & Forecasts, 2022-2032
10.1.2.3. Analytical Services Breakdown Size & Forecasts, 2022-2032
10.2. Europe Pharmaceutical Impurity Synthesis and Isolation Services Market
10.2.1. UK Pharmaceutical Impurity Synthesis and Isolation Services Market
10.2.2. Germany Pharmaceutical Impurity Synthesis and Isolation Services Market
10.2.3. France Pharmaceutical Impurity Synthesis and Isolation Services Market
10.2.4. Spain Pharmaceutical Impurity Synthesis and Isolation Services Market
10.2.5. Italy Pharmaceutical Impurity Synthesis and Isolation Services Market
10.2.6. Rest of Europe Pharmaceutical Impurity Synthesis and Isolation Services Market
10.3. Asia-Pacific Pharmaceutical Impurity Synthesis and Isolation Services Market
10.3.1. China Pharmaceutical Impurity Synthesis and Isolation Services Market
10.3.2. India Pharmaceutical Impurity Synthesis and Isolation Services Market
10.3.3. Japan Pharmaceutical Impurity Synthesis and Isolation Services Market
10.3.4. Australia Pharmaceutical Impurity Synthesis and Isolation Services Market
10.3.5. South Korea Pharmaceutical Impurity Synthesis and Isolation Services Market
10.3.6. Rest of Asia Pacific Pharmaceutical Impurity Synthesis and Isolation Services Market
10.4. Latin America Pharmaceutical Impurity Synthesis and Isolation Services Market
10.4.1. Brazil Pharmaceutical Impurity Synthesis and Isolation Services Market
10.4.2. Mexico Pharmaceutical Impurity Synthesis and Isolation Services Market
10.4.3. Rest of Latin America Pharmaceutical Impurity Synthesis and Isolation Services Market
10.5. Middle East & Africa Pharmaceutical Impurity Synthesis and Isolation Services Market
10.5.1. Saudi Arabia Pharmaceutical Impurity Synthesis and Isolation Services Market
10.5.2. South Africa Pharmaceutical Impurity Synthesis and Isolation Services Market
10.5.3. Rest of Middle East & Africa Pharmaceutical Impurity Synthesis and Isolation Services Market
Chapter 11. Competitive Intelligence 11.1. Key Company SWOT Analysis
11.1.1. Thermo Fisher Scientific Inc.
11.1.2. Merck KGaA
11.1.3. Charles River Laboratories International, Inc.
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Thermo Fisher Scientific Inc.
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Market Strategies
11.3.2. Merck KGaA
11.3.3. Charles River Laboratories International, Inc.
11.3.4. Agilent Technologies, Inc.
11.3.5. Waters Corporation
11.3.6. Eurofins Scientific
11.3.7. Wuxi AppTec
11.3.8. SGS SA
11.3.9. Toxikon Corporation
11.3.10. Alcami Corporation
Chapter 12. Research Process 12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes